Many lawsuits have been filed against the pharmaceutical companies associated with the birth control product NUVARING® in the United States.
NUVARING® is a birth control product that releases two synthetic hormones, etonogestrel (a progestin) and ethinyl estradiol (an estrogen), into the woman’s body.
The lawsuit complaints allege that the parties named as defendants, which includes Organon USA, Inc., Organon Pharmaceuticals USA, Inc., Organon International, Inc., Akzo Nobel NV, Organon Biosciences, N.V., and Schering-Plough Corporation, not only knew about the potential side effects associated with NUVARING®, but concealed those risks from the public, including the FDA during the approval process.
Continue reading